Adapting Your Respiratory Testing Algorithm in a Changing Reimbursement Landscape
36 Views • Sep-22-2017
Speakers: Charles Mathews, MPP Vice President, Boston Healthcare Margie Morgan, PhD, D(ABMM) Scientific Director Micr...
xTalks Webinar: Fecal Matters: Clinician & Laboratorian Perspective on Impact of Molecular GI Pathogen Testing”
56 Views • Sep-14-2017
Featured Speakers: Bert Lopansri, M.D. Chief, Intermountain Division of Infectious Diseases Medical Director of Intermount...
VERIGENE® System Workflow
1617 Views • Jan-16-2017
The VERIGENE® System offers automated, cost-effective multiplex capabilities that rapidly and accurately detect infectious path...
VERIGENE® RP Flex Overview
514 Views • Jan-16-2017
The VERIGENE® Respiratory Pathogens Flex Test (RP Flex) is an automated, multiplexed, flexible nucleic acid test for the identi...
Fecal Matters: Clinical Impact and Cost Effectiveness of Molecular GI Pathogen Testing
51 Views • Dec-19-2016
Flexible Testing for Respiratory Pathogens: Cost-Effectiveness and Impact on Clinician Ordering Patterns
86 Views • Dec-19-2016
This webinar discusses the needs for respiratory testing in diagnostics, including the broad range of viral pathogens, overlapp...
Flex Testing on the VERIGENE® System: Respiratory Pathogens and Beyond: AMP 2015 Workshop
30 Views • Dec-19-2016
This workshop highlights the clinical & economic value of VERIGENE's novel Flex™ testing solution. The Respiratory Pathogens Fl...
Each Hour Counts: Optimizing Therapy for Bloodstream Infections with Rapid Molecular Testing
49 Views • Dec-19-2016
Infections in the bloodstream carry a large disease burden and pose a great threat to human life. Delayed pathogen identificat...
Each Hour Counts: Improving Management of CRE’s and Other Antibiotic-Resistant BSI’s with Rapid Molecular Diagnostics
25 Views • Dec-19-2016
Traditional diagnostics for bloodstream infections can take 2-4 days, forcing clinicians to treat suspected bloodstream infecti...
Each Hour Counts: Physician and Pharmacist Perspectives on the Value of Rapid Blood Culture Testing
33 Views • Dec-19-2016
Sepsis is the most expensive condition to treat in the U.S. and is one of the deadliest diseases. Delayed identification of the...